Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

$2.8B

Market Cap • 4/2/2025

2018

(7 years)

Founded

2022

(3 years ago)

IPO

NASDAQ

Listing Exchange

Flag of LU

Luxembourg

Headquarters